Get the Stockscreener App
14.66
5.47%
0.76
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Dentsply Sirona Inc stock is traded at $14.66, with a volume of 2.28M.
It is up +5.47% in the last 24 hours and down -10.66% over the past month.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
See More
Previous Close:
$13.90
Open:
$14.02
24h Volume:
2.28M
Relative Volume:
0.79
Market Cap:
$2.92B
Revenue:
$3.90B
Net Income/Loss:
$-413.00M
P/E Ratio:
-7.0821
EPS:
-2.07
Net Cash Flow:
$365.00M
1W Performance:
+5.85%
1M Performance:
-10.66%
6M Performance:
-21.81%
1Y Performance:
-39.27%
1-Day Range:
$14.02
$14.71
1-Week Range:
$13.78
$14.71
52-Week Range:
$12.16
$27.48
Dentsply Sirona Inc Stock (XRAY) Company Profile
Name
Dentsply Sirona Inc
Sector
Industry
Phone
844-546-3722
Address
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
14.66 | 2.76B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-13-25 | Downgrade | Needham | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-23-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-07-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-25-24 | Reiterated | Needham | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Nov-16-23 | Initiated | Needham | Buy |
| Nov-10-23 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-12-23 | Upgrade | William Blair | Underperform → Mkt Perform |
| Aug-05-22 | Downgrade | William Blair | Mkt Perform → Underperform |
| Jun-02-22 | Upgrade | UBS | Neutral → Buy |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-19-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-09-21 | Reiterated | H.C. Wainwright | Neutral |
| Aug-06-21 | Reiterated | Barrington Research | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-02-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-02-21 | Reiterated | H.C. Wainwright | Neutral |
| Jan-05-21 | Reiterated | H.C. Wainwright | Neutral |
| Dec-18-20 | Downgrade | Stifel | Buy → Hold |
| Nov-17-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-09-20 | Reiterated | H.C. Wainwright | Neutral |
| Oct-22-20 | Upgrade | Guggenheim | Neutral → Buy |
| Aug-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Initiated | Piper Sandler | Overweight |
| Jun-15-20 | Reiterated | H.C. Wainwright | Neutral |
| May-27-20 | Upgrade | Evercore ISI | In-line → Outperform |
| May-11-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-24-20 | Reiterated | H.C. Wainwright | Neutral |
| Apr-08-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-07-20 | Downgrade | Goldman | Buy → Neutral |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-03-20 | Reiterated | H.C. Wainwright | Neutral |
| Feb-19-20 | Reiterated | Stifel | Buy |
| Dec-11-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-02-19 | Upgrade | Wellington Shields | Hold → Gradually Accumulate |
| Jul-26-19 | Initiated | Evercore ISI | In-line |
| Jul-09-19 | Reiterated | H.C. Wainwright | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
View All
Dentsply Sirona Inc Stock (XRAY) Latest News
Is DENTSPLY SIRONA Inc. Forming a Consolidation BaseJuly 2025 Snapshot & Free Weekly Chart Analysis and Trade Guides - classian.co.kr
Dentsply Sirona: Turnaround Potential And Digital Workflows (NASDAQ:XRAY) - Seeking Alpha
SureSmile clear aligners—a proven system for predictably treating malocclusion - Dental Tribune US
Dentures Market Future Business Opportunities 2025-2032 | Dentsply Sirona Inc., Ivoclar Vivadent Ag, GC America Inc - openPR.com
Dentsply Sirona shares rise 2.53% premarket after announcing the availability of CEREC Tessera®. - AInvest
CEOs linked to $3M+ home purchases in Charlotte - The Business Journals
Dental CAD-CAM Market Forecast and Company Analysis Report 2025-2029, with 3Shape, Align Technology, Carestream Dental, Dentsply Sirona, Jensen Dental, Schutz Dental, and Yenadent - Yahoo Finance
Digital Dentistry Solutions Market 9.90% CAGR Analysis with - openPR.com
Will DENTSPLY SIRONA Inc. announce a stock splitJuly 2025 Volume & High Conviction Investment Ideas - thegnnews.com
Can DENTSPLY SIRONA Inc. disrupt its industryBuy Signal & Risk Managed Investment Strategies - thegnnews.com
Dentsply Sirona Settled $84M Over Anti-Competitive Practices – How to Claim Your Payout - TradingView
Dentsply Sirona : Sustainability Report 2024 Fifth year of continued progress, with several goals reached ahead of time - MarketScreener
Dental Implants and Prosthetics Company Evaluation Report 2025 | Institut Straumann, Envista, and Dentsply Sirona Lead with Innovation and Expansive Portfolios - Yahoo Finance
Dental Burs Market 2025 | Size, Trends, Innovations & Global - openPR.com
Mizuho lowers Dentsply Sirona stock price target on margin concerns By Investing.com - Investing.com Canada
Stocks Surge Amid Fed Interest Rate Speculation: Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Among Winners - AInvest
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - uk.finance.yahoo.com
Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know | FinancialContent - FinancialContent
Analysts’ Top Healthcare Picks: DENTSPLY SIRONA (XRAY), Replimune Group (REPL) - The Globe and Mail
Healthcare Analysts Offer Insights on Trevi Therapeutics, DENTSPLY SIRONA, and Arrowhead Pharmaceuticals. - AInvest
DENTSPLY SIRONA, Replimune Group, and Enovis Analysts Maintain Neutral Ratings - AInvest
UFP Technologies, Inspire Medical Systems, Globus Medical, Neogen, and Dentsply Sirona stocks soar on positive inflation data, Fed rate cut hopes. - AInvest
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know - Yahoo Finance
Dentsply Sirona Requests to Dismiss Class Action Filed by Investors - TradingView
Intraoral radiography market to hit US$ 2.7 billion by 2031 | Top - openPR.com
Understanding The Growth Of The Clear Aligners Market By 2035 - PharmiWeb.com
International Markets and Dentsply (XRAY): A Deep Dive for Investors - Yahoo Finance
DENTSPLY SIRONA outlines $80M annualized tariff headwind, maintains full-year outlook as new CEO signals accelerated transformation - MSN
DENTSPLY SIRONA Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Dentsply Sirona Reports Q2 Earnings Below Expectations, Maintains FY25 Outlook - AInvest
Dentsply Sirona (XRAY) Q2 Sales Drop 5% - AOL.com
Dentsply Sirona shares fall 1.59% intraday after UBS trims price target to $24. - AInvest
Dentsply Sirona shares fall 4.16% intraday as UBS lowers price target to $24. - AInvest
Why Dentsply International (XRAY) is a Top Growth Stock for the Long-Term - Yahoo Finance
UBS Trims Dentsply Sirona Price Target to $24 From $25, Maintains Buy Rating - MarketScreener
Dentsply Sirona price target lowered to $24 from $25 at UBS - TipRanks
Dentsply Sirona Reports Q2 2025 Financial Results - TipRanks
Dentsply Sirona Maintains Outlook Despite Sales Decline - AOL.com
DENTSPLY's Q2 2025 Earnings Call: Unpacking Contradictions in Tariffs, Orthodontics, and Customer Support - AInvest
Jefferies lowers Dentsply Sirona stock price target to $15 on tariff concerns - Investing.com Canada
Dentsply Sirona shares rise 1.66% after-hours following Q2 earnings call with adjusted earnings rise. - AInvest
DENTSPLY SIRONA: Hold Rating Maintained Amidst Mixed Performance and Promising Margin Improvements - TipRanks
Dentsply Sirona’s (NASDAQ:XRAY) Q2 Earnings Results: Revenue In Line With Expectations - Yahoo Finance
DENTSPLY SIRONA Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Dentsply Sirona Q2 2025 sees earnings beat, stock rises - Investing.com
DENTSPLY SIRONA Q2 2025 Earnings Call Transcript - MarketBeat
XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up - Yahoo Finance
Deadline to Claim Your Payout from the $84M Dentsply Sirona Settlement Is in 2 Months - TradingView
Transcript : DENTSPLY SIRONA Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Dentsply (XRAY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
DENTSPLY SIRONA Inc. SEC 10-Q Report - TradingView
Dentsply Sirona Inc Stock (XRAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):